Evidence map›Paper›PMID 25801473›Full record

ReviewTrends in endocrinology and metabolism: TEM2015

The changing landscape in translocator protein (TSPO) function.

Vimal Selvaraj, Douglas M Stocco

Abstract readReview
In one paragraph

Review in Trends in endocrinology and metabolism: TEM, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. uPAR Immuno-PET in Pancreatic Cancer, Aging, and Chemotherapy-Induced Senescence.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2024
    Article
  8. Article
  9. Review
  10. Pharmaceutics · 2022
    Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Optimised GMP-compliant production of [EJNMMI radiopharmacy and chemistry · 2021
    Article
  17. Article
  18. Article
  19. Uric acid drives intestinal barrier dysfunction through TSPO-mediated NLRP3 inflammasome activation.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2021
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Vimal SelvarajDepartment of Animal Science, Cornell University, Ithaca, NY 14853, USA. Electronic address: vs88@cornell.edu.
Douglas M StoccoDepartment of Cell Biology and Biochemistry, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA.

Funding

MITOCHONDRIAL PROTEINS AND LEYDIG CELL STEROIDOGENESISR37HD017481 · NICHD · TEXAS TECH UNIVERSITY HEALTH SCIS CENTER · PI STOCCO, DOUGLAS M · 1996 to 2005
$1.9M
MITOCHONDRIAL PROTEINS AND LEYDIG CELL STEROIDOGENESISR01HD017481 · NICHD · TEXAS TECH UNIVERSITY HEALTH SCIS CENTER · PI STOCCO, DOUGLAS M · 1985 to 2011
$1.5M
NICHD NIH HHS HD-17481NICHD NIH HHS R01 HD017481NICHD NIH HHS R37 HD017481
6 · The paper itself

Abstract

Translocator protein (TSPO), previously known as the peripheral benzodiazepine receptor (PBR), is an outer mitochondrial membrane protein. TSPO has been shown to cooperate with steroidogenic acute regulatory protein (StAR) and function in the transport of cholesterol into mitochondria. TSPO has also been considered as a structural component of the mitochondrial permeability transition pore (MPTP). However, recent advances have changed these views of TSPO's functions and have prompted a re-evaluation of established concepts. This review summarizes the history of TSPO, key elements of the debate, and functional experiments that have changed our understanding. Moving forward, we examine how this fundamental change impacts our understanding of TSPO and affects the future of TSPO as a therapeutic and diagnostic target.

Indexed as

AnimalsBiomarkersHumansMitochondrial MembranesReceptors, GABASteroidsBiomarkersReceptors, GABASteroidsTSPO protein, humanbenzodiazepinecholesterolmitochondriapermeability transitionsteroid hormonetherapy

Identifiers

PMID25801473
PMCPMC7171652

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.